Cargando…
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study
PURPOSE: This study aims to predict hematological toxicity induced by (223)Ra therapy. We investigated the value of metabolically active bone tumor volume (MBTV) and total bone lesion activity (TLA) calculated on pretreatment fluorine-18-fluorocholine ((18)F-FCH) PET/CT in castrate-resistant prostat...
Autores principales: | Vija Racaru, Lavinia, Sinigaglia, Mathieu, Kanoun, Salim, Ben Bouallègue, Fayçal, Tal, Ilan, Brillouet, Sévérine, Bauriaud-Mallet, Mathilde, Zerdoud, Slimane, Dierickx, Lawrence, Vallot, Delphine, Caselles, Olivier, Gabiache, Erwan, Pascal, Pierre, Courbon, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023601/ https://www.ncbi.nlm.nih.gov/pubmed/29790867 http://dx.doi.org/10.1097/MNM.0000000000000850 |
Ejemplares similares
-
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
por: Deandreis, Désirée, et al.
Publicado: (2021) -
(18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA
por: Aziz, Anne-Laure, et al.
Publicado: (2015) -
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
por: Klain, Michele, et al.
Publicado: (2021) -
Interim and end-treatment (18)F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride
por: García Vicente, Ana María, et al.
Publicado: (2021) -
Diagnosis of an intestinal mucormycosis ‘fungus ball’ located with PET/CT with [(18)F] FDG-PET/CT
por: Gallo, Franklin, et al.
Publicado: (2019)